9
Participants
Start Date
June 30, 2016
Primary Completion Date
March 21, 2019
PQR309
taken continuously on daily basis (60mg, 80mg) or intermittent dosing (120mg, 140mg, 160mg)
Medizinische Klinik und Poliklinik III, Munich
Lead Sponsor
University Hospital, Basel, Switzerland
OTHER
University Hospital Munich
OTHER
University Hospital Freiburg
OTHER
Charite University, Berlin, Germany
OTHER
University of Stuttgart
OTHER
PIQUR Therapeutics AG
INDUSTRY